Literature DB >> 26919830

Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study.

Hao-Ying Dou1, Yuan-Yuan Wang1, Nan Yang1, Ming-Li Heng2, Xuan Zhou2, Huai-En Bu2, Fang Xu2, Tie-Niu Zhao2, He Huang3, Hong-Wu Wang4.   

Abstract

OBJECTIVE: To examine the association of genetic variants with characteristic symptoms of type 2 diabetes mellitus (T2DM).
METHODS: A matched case-control study was performed to investigate the association between common variants in four genes (CDKAL1, GLIS3, GRK5, and TCF7L2) and symptoms of T2DM. Symptoms were examined with questionnaire for 710 subjects. Genomic DNA was extracted from peripheral blood mononuclear cell by salting-out procedure. Genotyping was carried out by direct sequencing of the unpurified polymerase chain reaction products. RESULT: Most of the T2DM patients pressented characteristic symptoms, such as feeling weak in limbs (P =0.0057), hand tremor (P =0.0208), bradymasesis (P =0.0234), and polyuria (P =0.0051). Some of the T2DM patients shared characteristic symptoms, such as desire for cold drinks (P =0.0304), polyphagia (P =0.0051), and furred tongue (P =0.028). The impaired glucose regulation (IGR) cases took only one characteristic symptom of frequent micturition (P =0.0422). GLIS3 rs7034200 and GRK5 rs10886471 were significantly associated with increased T2DM risk (GLIS3 rs7034200 under dominant model: P=0.0307; GRK5 rs10886471 under recessive model: P=0.0092). However, only the rs10886471 polymorphism in GRK5 showed a significant effect on both differentiated symptoms and T2DM risk. The C-allele was involved in both dampness-heat encumbering Pi (Spleen) syndrome (P =0.047) and qi-yin deficiency syndrome (P =0.002) via increased GRK5 expression.
CONCLUSIONS: Both T2DM and IGR exhibited its corresponding characteristic symptoms. The variants of GRK5 were involved with both qi-yin deficiency syndrome and dampness-heat encumbering Pi syndrome.

Entities:  

Keywords:  Chinese medicine; genetic variants; impaired glucose regulation; syndromes; type 2 diabetes mellitus

Mesh:

Year:  2016        PMID: 26919830     DOI: 10.1007/s11655-015-2290-3

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  26 in total

1.  [Polymorphic markers TCF7L2 rs12255372 and SLC30A8 rs13266634 confer susceptibility to type 2 diabetes in a Russian population].

Authors:  V A Potapov; M N Shamkhalova; S A Smetanina; L N Bel'chikova; L A Suplotova; M V Shestakova; V V Nosikov
Journal:  Genetika       Date:  2010-08

Review 2.  Modification of insulin sensitivity and glycemic control by activity and exercise.

Authors:  Christian K Roberts; Jonathan P Little; John P Thyfault
Journal:  Med Sci Sports Exerc       Date:  2013-10       Impact factor: 5.411

3.  Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats.

Authors:  Zhong Zhen; Bai Chang; Min Li; Feng-Mei Lian; Liang Chen; Liu Dong; Jia Wang; Bo Yu; Wen-Ke Liu; Xiu-Yang Li; Pei-Jie Qin; Jing-Hua Zhang; Xiao-Lin Tong
Journal:  Am J Chin Med       Date:  2011       Impact factor: 4.667

4.  Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice.

Authors:  Wei-Han Chueh; Jin-Yuarn Lin
Journal:  J Agric Food Chem       Date:  2011-07-01       Impact factor: 5.279

5.  Radix astragali (huangqi) as a treatment for defective hypoglycemia counterregulation in diabetes.

Authors:  Zhen Sang; Ligang Zhou; Xiaoning Fan; Rory J McCrimmon
Journal:  Am J Chin Med       Date:  2010       Impact factor: 4.667

6.  Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression.

Authors:  Hong Soon Kang; Yong-Sik Kim; Gary ZeRuth; Ju Youn Beak; Kevin Gerrish; Gamze Kilic; Beatriz Sosa-Pineda; Jan Jensen; Christophe E Pierreux; Frederic P Lemaigre; Julie Foley; Anton M Jetten
Journal:  Mol Cell Biol       Date:  2009-10-05       Impact factor: 4.272

7.  Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes.

Authors:  Nian Wang; Deling Zhang; XianQing Mao; Feng Zou; Huan Jin; JingPing Ouyang
Journal:  Mol Cell Endocrinol       Date:  2009-03-14       Impact factor: 4.102

8.  Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.

Authors:  Richa Saxena; Clara C Elbers; Yiran Guo; Inga Peter; Tom R Gaunt; Jessica L Mega; Matthew B Lanktree; Archana Tare; Berta Almoguera Castillo; Yun R Li; Toby Johnson; Marcel Bruinenberg; Diane Gilbert-Diamond; Ramakrishnan Rajagopalan; Benjamin F Voight; Ashok Balasubramanyam; John Barnard; Florianne Bauer; Jens Baumert; Tushar Bhangale; Bernhard O Böhm; Peter S Braund; Paul R Burton; Hareesh R Chandrupatla; Robert Clarke; Rhonda M Cooper-DeHoff; Errol D Crook; George Davey-Smith; Ian N Day; Anthonius de Boer; Mark C H de Groot; Fotios Drenos; Jane Ferguson; Caroline S Fox; Clement E Furlong; Quince Gibson; Christian Gieger; Lisa A Gilhuijs-Pederson; Joseph T Glessner; Anuj Goel; Yan Gong; Struan F A Grant; Diederick E Grobbee; Claire Hastie; Steve E Humphries; Cecilia E Kim; Mika Kivimaki; Marcus Kleber; Christa Meisinger; Meena Kumari; Taimour Y Langaee; Debbie A Lawlor; Mingyao Li; Maximilian T Lobmeyer; Anke-Hilse Maitland-van der Zee; Matthijs F L Meijs; Cliona M Molony; David A Morrow; Gurunathan Murugesan; Solomon K Musani; Christopher P Nelson; Stephen J Newhouse; Jeffery R O'Connell; Sandosh Padmanabhan; Jutta Palmen; Sanjey R Patel; Carl J Pepine; Mary Pettinger; Thomas S Price; Suzanne Rafelt; Jane Ranchalis; Asif Rasheed; Elisabeth Rosenthal; Ingo Ruczinski; Sonia Shah; Haiqing Shen; Günther Silbernagel; Erin N Smith; Annemieke W M Spijkerman; Alice Stanton; Michael W Steffes; Barbara Thorand; Mieke Trip; Pim van der Harst; Daphne L van der A; Erik P A van Iperen; Jessica van Setten; Jana V van Vliet-Ostaptchouk; Niek Verweij; Bruce H R Wolffenbuttel; Taylor Young; M Hadi Zafarmand; Joseph M Zmuda; Michael Boehnke; David Altshuler; Mark McCarthy; W H Linda Kao; James S Pankow; Thomas P Cappola; Peter Sever; Neil Poulter; Mark Caulfield; Anna Dominiczak; Denis C Shields; Deepak L Bhatt; Deepak Bhatt; Li Zhang; Sean P Curtis; John Danesh; Juan P Casas; Yvonne T van der Schouw; N Charlotte Onland-Moret; Pieter A Doevendans; Gerald W Dorn; Martin Farrall; Garret A FitzGerald; Anders Hamsten; Robert Hegele; Aroon D Hingorani; Marten H Hofker; Gordon S Huggins; Thomas Illig; Gail P Jarvik; Julie A Johnson; Olaf H Klungel; William C Knowler; Wolfgang Koenig; Winfried März; James B Meigs; Olle Melander; Patricia B Munroe; Braxton D Mitchell; Susan J Bielinski; Daniel J Rader; Muredach P Reilly; Stephen S Rich; Jerome I Rotter; Danish Saleheen; Nilesh J Samani; Eric E Schadt; Alan R Shuldiner; Roy Silverstein; Kandice Kottke-Marchant; Philippa J Talmud; Hugh Watkins; Folkert W Asselbergs; Folkert Asselbergs; Paul I W de Bakker; Jeanne McCaffery; Cisca Wijmenga; Marc S Sabatine; James G Wilson; Alex Reiner; Donald W Bowden; Hakon Hakonarson; David S Siscovick; Brendan J Keating
Journal:  Am J Hum Genet       Date:  2012-02-09       Impact factor: 11.025

9.  PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.

Authors:  Cheng Hu; Rong Zhang; Congrong Wang; Jie Wang; Xiaojing Ma; Jingyi Lu; Wen Qin; Xuhong Hou; Chen Wang; Yuqian Bao; Kunsan Xiang; Weiping Jia
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

10.  Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial.

Authors:  Linong Ji; Hongmei Li; Xiaohui Guo; Yan Li; Renming Hu; Zhengying Zhu
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  5 in total

Review 1.  GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases.

Authors:  Anton M Jetten
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

Review 2.  Research Progress on Non-Drug Treatment for Blood Glucose Control of Type 2 Diabetes Mellitus.

Authors:  Jun-Ping Wei; Qiu-Hong Wang; Hui-Juan Zheng; Fan Wei
Journal:  Chin J Integr Med       Date:  2018-07-25       Impact factor: 1.978

3.  Association Between Single Nucleotide Polymorphisms in CDKAL1 and HHEX and Type 2 Diabetes in Chinese Population.

Authors:  Chuanyin Li; Keyu Shen; Man Yang; Ying Yang; Wenyu Tao; Siqi He; Li Shi; Yufeng Yao; Yiping Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-05       Impact factor: 3.168

4.  Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans.

Authors:  Stefan Z Lutz; Mathias Falcenberg; Fausto Machicao; Andreas Peter; Martin Kächele; Elko Randrianarisoa; Angela Lehn-Stefan; Robert Wagner; Jürgen Machann; Fritz Schick; Martin Heni; Axel Ullrich; Andreas Fritsche; Norbert Stefan; Hans-Ulrich Häring; Harald Staiger; Konstantinos Kantartzis
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

5.  FBXW7 gene polymorphism is associated with type 2 diabetes in the Uygur population in Xinjiang, China.

Authors:  Shi-Qi Yan; Dilare Adi; Cheng Liu; Meng-Meng Wang; Jialin Abuzhalihana; Yun Wu; Zhen-Yan Fu; Yi-Ning Yang; Xiao-Mei Li; Xiang Xie; Fen Liu; Bang-Dang Chen; Yi-Tong Ma
Journal:  Hereditas       Date:  2021-08-09       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.